Adequacy of empirical antifungal therapy and effect on outcome among patients with invasive Candida species infections
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
OBJECTIVES: Although inadequate antimicrobial therapy has been demonstrated in multiple studies to increase the risk for death in bacterial infections, few data investigating the effect of antifungal therapy on outcome of serious fungal disease are available. We sought to assess the adequacy of empirical therapy and its effect on mortality in invasive Candida species infections. METHODS: Population-based surveillance of all patients with Candida spp. cultured from blood and/or cerebrospinal fluid was conducted. Adequacy of empirical therapy was assessed according to published guidelines. RESULTS: During a 5 year period, 207 patients had an invasive Candida spp. infection identified; in 199 cases (96%) adequate data were available for assessment of treatment and outcome at hospital discharge. One hundred and three (52%) cases were due to Candida albicans, 44 (22%) were due to Candida glabrata and the remainder were due to other species. Between the time of culture draw and reporting of a positive culture, only 64 (32%) patients were treated with empirical therapy; this was deemed adequate in 51 (26%). Patients who received adequate empirical therapy had a significant decrease in crude mortality [14/51 (27%) versus 68/148 (46%); risk ratio 0.60 (95% confidence interval 0.37-0.96); P = 0.02]. After adjusting for age and the need for intensive care unit admission in logistic regression analysis, the use of adequate empirical therapy was independently associated with a reduced risk for death [odds ratio 0.46 (95% confidence interval 0.22-1.00); P = 0.05]. CONCLUSIONS: Adequate empirical therapy is used in a minority of patients with invasive Candida spp. infections but is associated with improved survival.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although retrospective studies have suggested that empiric antifungal therapy might improve survival for select high-risk patients [28]”
From Treatment practices for adults with candidemia at 9 active surveillance sites—United States, 2017–2018. (2021) · cites this paper as [28]
Citations
Cites
National Committee for Clinical Laboratory Standards
Bruck, E. (1980) · Pediatrics · doi:10.1542/peds.65.1.187 · Cited by 14,751
Kumar, A., Roberts, D., Wood, K. E., Light, B., Parrillo, J. E., Sharma, S., Suppes, R., Feinstein, D., Zanotti, S., Taiberg, L., et al. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000217961.75225.e9 · Cited by 6,109 · cited 2×
“Lastly, Kumar et al. 28 were able to demonstrate an increase in mortality with each hour of treatment delay in fungal septic shock (RR 1.06).”
BackgroundInfluentialInadequate Antimicrobial Treatment of Infections
Kollef, M. H., Sherman, G., Ward, S., & Fraser, V. J. (1999) · Chest · doi:10.1378/chest.115.2.462 · Cited by 1,805
Ibrahim, E. H., Sherman, G., Ward, S., Fraser, V. J., & Kollef, M. H. (2000) · Chest · doi:10.1378/chest.118.1.146 · Cited by 1,779 · cited 2×
“Inappropriate initial antimicrobial therapies have been linked with increased patient fatality.(14) – 17,24,25 Subsequent corrected regimens following microbiological identification of the pathogen have not been associated with improved patient survival, thus highlighting the critical importance of correct initial ant…”
BackgroundGuidelines for Treatment of Candidiasis
Pappas, P. G., Rex, J. H., Sobel, J. D., Filler, S. G., Dismukes, W. E., Walsh, T. J., & Edwards, J. E. (2004) · Clinical Infectious Diseases · doi:10.1086/380796 · Cited by 1,440 · cited 2×
“Accordingly, many experts advocate early empirical antifungal therapies in patients deemed high risk.(2,20,21) However, no studies to date have specifically addressed the role of empirical antifungal therapies on patient outcome.”
BackgroundMethodNosocomial Bloodstream Infections in United States Hospitals: A Three‐Year Analysis
Edmond, M. B., Wallace, S. E., McClish, D. K., Pfaller, M. A., Jones, R. N., & Wenzel, R. P. (1999) · Clinical Infectious Diseases · doi:10.1086/520192 · Cited by 1,387
Morrell, M., Fraser, V. J., & Kollef, M. H. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.9.3640-3645.2005 · Cited by 1,286
Garey, K. W., Rege, M., Pai, M. P., Mingo, D. E., Suda, K. J., Turpin, R. S., & Bearden, D. T. (2006) · Clinical Infectious Diseases · doi:10.1086/504810 · Cited by 1,171 · cited 3×
“Garey et al. 18 further demonstrated in a multicentre retrospective study that for each successive day of delay in receipt of fluconazole treatment there was an increase in patient mortality.”
BackgroundHospital-Acquired Candidemia: The Attributable Mortality and Excess Length of Stay
Wey, S. B. (1988) · Archives of Internal Medicine · doi:10.1001/archinte.1988.00380120094019 · Cited by 831
Trick, W. E., Fridkin, S. K., Edwards, J. R., Hajjeh, R. A., Gaynes, R. P., & Hospitals, T. N. N. I. S. S. (2002) · Clinical Infectious Diseases · doi:10.1086/342300 · Cited by 660
Cited by
Items 101–200 of 237
Chalmers, C., Gaur, S., Chew, J., Wright, T., Kumar, A., Mathur, S., Wan, W. Y., Gould, I. M., Leanord, A., & Bal, A. M. (2011) · Mycoses · doi:10.1111/j.1439-0507.2011.02027.x · Cited by 35
Epidemiología de las candidiasis invasoras en población pediátrica y adulta
del Palacio, A., Villar, J., & Alhambra, A. (2009) · Revista Iberoamericana de Micología · doi:10.1016/s1130-1406(09)70002-6 · Cited by 35
Li, Y., Du, M., Chen, L., Liu, Y., & Liang, Z. (2016) · Mycopathologia · doi:10.1007/s11046-016-9997-3 · Cited by 35
Alvarez-Rueda, N., Fleury, A., Morio, F., Pagniez, F., Gastinel, L., & Le Pape, P. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021239 · Cited by 34
Pfaller, M. A., Boyken, L. B., Hollis, R. J., Kroeger, J., Messer, S. A., Tendolkar, S., & Diekema, D. J. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.02437-10 · Cited by 34
Zheng, Y., Xie, T., Wu, L., Liu, X.-Y., Zhu, L. Y., Chen, Y., Mao, E., Han, L., Chen, E., & Yang, Z. (2021) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/s12941-021-00441-y · Cited by 34
Early antifungal intervention strategies in ICU patients
Eggimann, P., & Ostrosky-Zeichner, L. L. (2010) · Current Opinion in Critical Care · doi:10.1097/mcc.0b013e32833e0487 · Cited by 34
Kludze-Forson, M., Eschenauer, G. A., Kubin, C. J., Della‐Latta, P., & Lam, S. W. (2009) · Medical Mycology · doi:10.3109/13693780903208256 · Cited by 33
The Epidemiology of Invasive Candidiasis
Pfaller, M. A., & Diekema, D. J. (2014) · Candida and Candidiasis · doi:10.1128/9781555817176.ch29 · Cited by 33
Ala‐Houhala, M., Valkonen, M. M., Kolho, E., Friberg, N., & Anttila, V.-J. (2019) · Scandinavian Journal of Infectious Diseases · doi:10.1080/23744235.2019.1662941 · Cited by 33
Micafungin: an evidence-based review of its place in therapy
Reboli, A. C., & de la Torre (2014) · Core evidence · doi:10.2147/ce.s36304 · Cited by 31
Invasive Candida species infection: the importance of adequate empirical antifungal therapy
Armstrong-James, D. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm260 · Cited by 31
Leenders, N. H. J., Oosterheert, J. J., Ekkelenkamp, M. B., de Lange, D. W., Hoepelman, A. I. M., & Peters, E. J. G. (2011) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2011.03.009 · Cited by 31
Management of Invasive Candidiasis in the Intensive Care Unit
Playford, E. G., Lipman, J., & Sorrell, T. C. (2010) · Drugs · doi:10.2165/10898550-000000000-00000 · Cited by 30
Chen, P., Wu, H., Zhao, Y., Zhong, L., Zhang, Y., Zhan, X., Xiao, A., Huang, Y., Zhang, H., & Guan, B. (2024) · Advanced Materials · doi:10.1002/adma.202312985 · Cited by 30
Treatment of critically ill patients with candidemia
Mensa, J., Pitart, C., & Marco, F. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(08)70007-4 · Cited by 26
Optimizing Antimicrobial Therapy in Sepsis and Septic Shock
Kumar, A. (2011) · Critical Care Nursing Clinics of North America · doi:10.1016/j.ccell.2010.12.005 · Cited by 26
Borman, A. M., Székely, A., Palmer, M. D., & Johnson, E. M. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.00913-12 · Cited by 25
Anidulafungin for the treatment of invasive candidiasis
Mayr, A., Aigner, M., & Lass‐Flörl, C. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03448.x · Cited by 25
Initial antifungal strategy does not correlate with mortality in patients with candidemia
Murri, R., Scoppettuolo, G., Ventura, G., Fabbiani, M., Giovannenze, F., Taccari, F., Milozzi, E., Posteraro, B., Sanguinetti, M., Cauda, R., et al. (2015) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-015-2527-2 · Cited by 24
González-Lara, M. F., Torres‐González, P., Cornejo‐Juárez, P., Velázquez-Acosta, C., Martínez‐Gamboa, A., Rangel‐Cordero, A., Bobadilla-del-Valle, M., Ostrosky-Zeichner, L. L., Ponce‐de‐León, A., & Sifuentes‐Osornio, J. (2017) · BMC Infectious Diseases · doi:10.1186/s12879-017-2846-2 · Cited by 24
Alothman, A. F., Althaqafi, A., Matar, M. J., Moghnieh, R., Alenazi, T. H., Farahat, F. M., Corman, S. L., Solem, C. T., Raghubir, N., Macahilig, C. P., et al. (2017) · Infection and Drug Resistance · doi:10.2147/idr.s97413 · Cited by 24
Alobaid, K., & Khan, Z. (2018) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2018.12.001 · Cited by 23
Treatment of invasive candidiasis with echinocandins
Glöckner, A., Steinbach, A., Vehreschild, J. J., & Cornely, O. A. (2009) · Mycoses · doi:10.1111/j.1439-0507.2008.01645.x · Cited by 23
An observational study on the epidemiological and mycological profile of Candidemia in ICU patients
Kotwal, A., Biswas, D., Sharma, J. P., Gupta, A., & Jindal, P. (2011) · Medical Science Monitor · doi:10.12659/msm.882053 · Cited by 23
Bourassa‐Blanchette, S., Biesheuvel, M. M., Lam, J. C., Kipp, A. J., Church, D. L., Carson, J. A., Dalton, B., Parkins, M. D., Barkema, H. W., & Gregson, D. B. (2023) · BMC Infectious Diseases · doi:10.1186/s12879-023-08050-0 · Cited by 22
Self-citationDupont, H., Mahjoub, Y., Chouaki, T., Lorne, E., & Zogheib, E. H. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002698 · Cited by 22
Hof, H. (2008) · Mycoses · doi:10.1111/j.1439-0507.2008.01522.x · Cited by 22
The Diagnostic and Therapeutic Approach to Fungal Infections in Critical Care Settings
Zaragoza, R., & Pemán, J. (2008) · Cited by 21
Hacia el diagnóstico temprano de la candidiasis invasora en el paciente crítico
Pemán, J., & Zaragoza, R. (2012) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2012.03.002 · Cited by 21
Ahmad, S., Kumar, S., Rajpal, K., Sinha, R., Kumar, R., Muni, S., & Kumari, N. (2022) · Cureus · doi:10.7759/cureus.24612 · Cited by 21
Gold, J. A. W., Seagle, E. E., Nadle, J., Barter, D. M., Czaja, C. A., Johnston, H., Farley, M. M., Thomas, S., Harrison, L. H., Fischer, J., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab512 · Cited by 20
Miyazaki, T., & Kohno, S. (2015) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2015.1058157 · Cited by 20
Dekio, F., Bhatti, T. R., Zhang, S. X., & Sullivan, K. V. (2015) · American Journal of Clinical Pathology · doi:10.1309/ajcpemvyt88avfkg · Cited by 20
Zhang, M., Rao, Z.-G., Ma, T., Tang, M., Xu, T., He, X.-X., Li, Z.-P., Liu, Y., Xu, Q.-J., Yang, K., et al. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.952611 · Cited by 19
Direct fluconazole susceptibility testing of positive Candida blood cultures by flow cytometry
Rudensky, B., Broide, E., Berko, N., Weil‐Weiner, Y., Yinnon, A. M., & Raveh, D. (2007) · Mycoses · doi:10.1111/j.1439-0507.2007.01466.x · Cited by 19
Tratamiento de las infecciones fúngicas en pacientes con neoplasias hematológicas
Mensa, J., de la Cámara, R., Carreras, E., Estrella, M. C., Rodríguez, J. Á. G., Gobernado, M., Picazo, J., Aguado, J. M., & Sanz, M. Á. (2009) · Medicina Clínica · doi:10.1016/j.medcli.2009.01.008 · Cited by 19
A Risk Score for Fluconazole Failure among Patients with Candidemia
Ostrosky-Zeichner, L. L., Harrington, R. L., Azie, N. E., Yang, H., Li, N., Zhao, J., Koo, V., & Wu, E. Q. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02091-16 · Cited by 19
Management of fungal infections in the intensive care unit: a survey of UK practice
Chalmers, C., & Bal, A. M. (2011) · British Journal of Anaesthesia · doi:10.1093/bja/aer089 · Cited by 19
Defining standards of CARE for invasive fungal diseases in the ICU
Cuenca‐Estrella, M., Kett, D. H., & Wauters, J. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz038 · Cited by 18
Sáez‐Rosón, A., Sevilla, M.-J., & Moragues, M. D. (2014) · PubMed · doi:10.2436/20.1501.01.204 · Cited by 18
Alvarez-Rueda, N., Fleury, A., Logé, C., Pagniez, F., Robert, E., Morio, F., & Pape, P. L. (2016) · Medical Mycology · doi:10.1093/mmy/myw023 · Cited by 18
Selective Digestive Tract Decontamination: A Tough Pill to Swallow
Laupland, K. B., & Fisman, D. N. (2009) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2009/290130 · Cited by 17
Self-citationLockhart, S. R., Bolden, C. B., Iqbal, N. J., & Kuykendall, R. J. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.05479-11 · Cited by 16
Molecular Techniques and Target Selection for the Identification of Candida spp. in Oral Samples
Magalhães, J., Correia, M. J., Silva, R. M., Esteves, A. C., Alves, A., & Duarte, A. S. (2022) · Applied Sciences · doi:10.3390/app12189204 · Cited by 16
Grau, S., Salavert, M., Laderas, J. C. P., Vargas, M., Barrueta, J. A., & Mir, N. (2013) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2013.05.004 · Cited by 15
Zatta, M., Bella, S. D., Giacobbe, D. R., Puente, F. D., Merelli, M., Azzini, A. M., Brugnaro, P., Vedovelli, C., Cattelan, A. M., Busetti, M., et al. (2020) · Gerontology · doi:10.1159/000510638 · Cited by 15
Karthaus, M., Rüping, M. J. G. T., Cornely, O. A., Steinbach, A., Groll, A. H., Lass‐Flörl, C., Ostermann, H., Ruhnke, M., & Vehreschild, J. J. (2011) · Mycoses · doi:10.1111/j.1439-0507.2010.01988.x · Cited by 14
Lee, W., Liew, Y., Chlebicki, M. P., Ong, S. G. K., Lee, P., & Kwa, A. L. (2014) · Critical Care Research and Practice · doi:10.1155/2014/479413 · Cited by 14
Ahmadi, A., Ardehali, S. H., Beigmohammadi, M. T., Hajiabdolbaghi, M., Hashemian, S. M. R., Kouchek, M., Majidpour, A., Mokhtari, M., Moghaddam, O. M., Najafi, A., et al. (2014) · JRSM Open · doi:10.1177/2042533313517689 · Cited by 14
Geersing, T. H., Franssen, E. J. F., Spronk, P. E., van Kan, H. J. M., den Reijer, M., & van der Voort, P. H. J. (2021) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkab372 · Cited by 14
Cui, N., Wang, H., Qiu, H., Li, R., & Liu, D. (2017) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2017.02.019 · Cited by 13
Marchena‐Gómez, J., Saez‐Guzman, T., Hemmersbach‐Miller, M., Martel, A. C., León, V. M., Benítez, A. B., & Acosta‐Mérida, M. A. (2009) · World Journal of Surgery · doi:10.1007/s00268-009-0120-5 · Cited by 13
Candidemia in the critically ill: initial therapy and outcome in mechanically ventilated patients
Ferrada, M. A., Quartin, A. A., Kett, D. H., & Morris, M. I. (2013) · BMC Anesthesiology · doi:10.1186/1471-2253-13-37 · Cited by 12
JSMM Clinical Practice Guidelines for Diagnosis and Treatment of Invasive Candidiasis
(2013) · Medical Mycology Journal · doi:10.3314/mmj.54.147 · Cited by 12
Update: invasive Pilzinfektionen
Lichtenstern, C., Swoboda, S., Hirschburger, M., Domann, E., Hoppe‐Tichy, T., Winkler, M., Lass‐Flörl, C., & Weigand, M. A. (2010) · Der Anaesthesist · doi:10.1007/s00101-009-1655-4 · Cited by 12
Nosocomial candidemia in adults: Risk and prognostic factors
Gürcüoğlu, E., Akalın, H., Ener, B., Ocakoğlu, G., Sınırtaş, M., Akçağlar, S., Yılmaz, E., Evci, C., & Oral, H. B. (2010) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2010.07.006 · Cited by 12
Strategies to manage antifungal drug resistance
Tseng, H.-K., & Perfect, J. R. (2011) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2010.517195 · Cited by 11
Wennerås, C., Hagberg, L., Andersson, R., Hynsjö, L., Lindahl, A. H., Okrój, M., Blom, A. M., Johansson, P., Andréasson, B., Gottfries, J., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092319 · Cited by 11
Leroy, O., Mira, J. P., Montravers, P., Gangneux, J., Gouin, F., Sollet, J.-P., Carlet, J. M., Reynes, J., Rosenheim, M., Regnier, B., et al. (2008) · Annales Françaises d Anesthésie et de Réanimation · doi:10.1016/j.annfar.2008.10.004 · Cited by 11
Utility of Antifungal Susceptibility Testing and Clinical Correlations
Diekema, D. J., & Pfaller, M. A. (2011) · Humana Press eBooks · doi:10.1007/978-1-59745-134-5_8 · Cited by 10
Marchetti, O., Eggimann, P., & Calandra, T. (2010) · Current Opinion in Critical Care · doi:10.1097/mcc.0b013e32833e2629 · Cited by 9
Pagès, A., Iriart, X., Molinier, L., Georges, B., Berry, A., Massip, P., & Juillard‐Condat, B. (2017) · Value in Health · doi:10.1016/j.jval.2017.06.009 · Cited by 9
Invasive candidiasis in critically ill patients
Kaaniche, F. M., Allela, R., Cherif, S., & Algia, N. B. (2016) · Trends in Anaesthesia and Critical Care · doi:10.1016/j.tacc.2016.11.002 · Cited by 7
Diagnostic of Fungal Infections Related to Biofilms
Sanguinetti, M., & Posteraro, B. (2016) · Advances in experimental medicine and biology · doi:10.1007/5584_2016_9 · Cited by 7
Ochiuzzi, M. E., Arechavala, A. I., Guelfand, L. I., Maldonado, I., & Soloaga, R. N. (2014) · Revista Argentina de Microbiología · doi:10.1016/s0325-7541(14)70058-6 · Cited by 7
Leitliniengerechte Therapie: Candidämie/invasive Candidiasis
Glöckner, A. (2010) · Mycoses · doi:10.1111/j.1439-0507.2009.01838.x · Cited by 7
Maldonado, I., Canigia, L. F., Vivot, W., Domecq, P., Davel, G., & Córdoba, S. B. (2011) · PubMed · doi:10.1590/s0325-75412011000200010 · Cited by 6
The “De-escalation Concept” and Antibiotic De-escalation: A Missed Opportunity?
Camargo, L. F. A. (2013) · Shock · doi:10.1097/shk.0b013e31828faf02 · Cited by 5
Terminal-stage prognostic analysis in candidemia
Takuma, T., Shoji, H., & Niki, Y. (2015) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2015.01.007 · Cited by 5
Épidémiologie des candidoses invasives en France
Charles, P., Large, A., Quenot, J., & Dalle, F. (2016) · Réanimation · doi:10.1007/s13546-016-1183-6 · Cited by 5
Dash, C., Pal, A., & Sinha, S. (2019) · International Journal of Advances in Medicine · doi:10.18203/2349-3933.ijam20191169 · Cited by 5
Use of MALDI-TOF Mass Spectrometry in Fungal Diagnosis
de Luna, F. F.-Á. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-814451-0.00014-9 · Cited by 5
Galactomannan and Anti- Aspergillus Antibody Detection for the Diagnosis of Invasive Aspergillosis
Verweij, P. E. (2014) · ASM Press eBooks · doi:10.1128/9781555815523.ch28 · Cited by 4
Management of invasive fungal infections in the pediatric intensive care unit
Fisher, B. T., Zaoutis, T. E., & Chiotos, K. (2015) · Journal of Pediatric Intensive Care · doi:10.3233/pic-14108 · Cited by 4
Verma, N., Valsan, A., Garg, P., Sarabu, S., Kaur, P., Mohan, N., De, A., Premkumar, M., Taneja, S., Prinja, S., et al. (2025) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000003832 · Cited by 4
Anidulafungin: Review of its Role in the Treatment of Invasive Candidiasis
de la Torre, P., & Reboli, A. C. (2011) · Clinical Medicine Insights Therapeutics · doi:10.4137/cmt.s3153 · Cited by 4
Epidemiology, Risk Factors and Mortality of Candidemia: Case-control Study
Özdemir, K., Kocaoğlu, C., Kutlu, S. S., Ergin, Ç., & Kutlu, M. (2020) · Flora the Journal of Infectious Diseases and Clinical Microbiology · doi:10.5578/flora.68736 · Cited by 4
L’albumine endogène : un pouvoir anti-oxydant majeur
Mira, J. P. (2008) · Réanimation · doi:10.1016/s1624-0693(08)73934-3 · Cited by 4
Takesue, Y., Oda, S., Fujishima, S., Aikawa, N., & Mikamo, H. (2012) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-012-0371-1 · Cited by 4
Impact of COVID-19 on candidemia: Risk factors and outcomes in a southeastern US cohort
Endashaw, M., Dykes, A., Clark, R., Warrayat, L., Hodges, M. J., Deng, S., Chen, X., Henao‐Martínez, A. F., & Chastain, D. B. (2025) · Medical Mycology · doi:10.1093/mmy/myaf103 · Cited by 3
Molecular Diagnosis in Fungal Infection Control
Vanichanan, J., & Ostrosky-Zeichner, L. L. (2015) · Current treatment options in infectious diseases/Current treatment options in infectious disease · doi:10.1007/s40506-015-0040-x · Cited by 3
Particularidades clínicas del paciente crítico con infección fúngica invasora
Borges-Sa, M., & Aranda-Pérez, M. (2012) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2012.03.008 · Cited by 3
Open Abdomen Management and Candida Infections: A Very Likely Link
Occhionorelli, S., Zese, M., Cultrera, R., Lacavalla, D., Albanese, M., & Vasquez, G. (2017) · Gastroenterology Research and Practice · doi:10.1155/2017/5187620 · Cited by 3
Invasive candidiasis following liver transplantation and surgical complications
Auzinger, G. M. (2011) · Mycoses · doi:10.1111/j.1439-0507.2011.02135.x · Cited by 3
Emerging fungal pathogens:a major threat to human life
Harsha, M., Venkatachalam, S., Pooja, M., & Paranjothy, M. (2017) · International Journal of Pharmaceutical Sciences and Research · doi:10.13040/ijpsr.0975-8232.8(5).1923-34 · Cited by 3
Almeida, L. M. C., Diniz, M. D. S., Diniz, L. D. S., Machado‐Pinto, J., & Silva, F. C. L. (2013) · Anais Brasileiros de Dermatologia · doi:10.1590/abd1806-4841.20131912 · Cited by 3
Zingg, W., Eggimann, P., & Pittet, D. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-1367-1.00132-4 · Cited by 2
Indication des traitements antifongiques (hors hématologie). Que montrent les données ?
Huette, P., & Dupont, H. (2019) · Anesthésie & Réanimation · doi:10.1016/j.anrea.2019.03.004 · Cited by 2
Erratum to: An Italian consensus for invasive candidiasis management (ITALIC)
Scudeller, L., Viscoli, C., Menichetti, F., Bono, V. D., Cristini, F., Tascini, C., Bassetti, M., & Viale, P. (2014) · Infection · doi:10.1007/s15010-013-0577-x · Cited by 2
Ferrer, R., Zaragoza, R., Llinares, P., Maseda, E., Rodríguez, A. H., & Quindós, G. (2016) · Medicina Intensiva (English Edition) · doi:10.1016/j.medin.2016.07.003 · Cited by 2
Yamada, G., Iwamoto, N., Ishikane, M., Moriya, A., Kurokawa, M., Mezaki, K., & Ohmagari, N. (2022) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofac667 · Cited by 2
Echinocandine bei invasiven Candida-Infektionen
Glöckner, A., & Cornely, O. A. (2008) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-008-1058-3 · Cited by 2
Moulds: diagnosis and treatment
Verweij, P. E., & Maertens, J. A. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp080 · Cited by 2
Characterisation of Candida species : a case study in three teaching hospitals in Ghana.
Adjapong, G. (2014) · UC Research Repository (University of Canterbury) · doi:10.26021/8140 · Cited by 2
New Molecular Method for Detection of Candidemia, but Don’t Forget the Blood Cultures
Hawley, H. B. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/cix1101 · Cited by 1
Antimicrobial activity and immunological side effects of different antibiotics.
Dorić, M., Abram, M., & Rukavina, T. (1993) · PubMed · Cited by 1
Subramanian, R., Kalva, S., & Ramaraj, V. K. (2019) · Research Journal of Life Sciences Bioinformatics Pharmaceutical and Chemical Sciences · doi:10.26479/2019.0502.58 · Cited by 1
Sawyer, R., Chou, J., McLaren, G., & Cheng, A. W. (2022) · World Journal of Surgical Infection · doi:10.4103/wjsi.wjsi_13_22 · Cited by 1
Infections fongiques en réanimation
Soulier-Zaninka, Q., Lefebvre, T., Bayart, G., Viart, C., Tarpin, P., & Dupont, H. (2024) · Anesthésie & Réanimation · doi:10.1016/j.anrea.2023.11.003 · Cited by 1
Metadata
- Authors
- Parkins, M. D., Sabuda, D. M., Elsayed, S., & Laupland, K. B.
- Affiliations
- University of Calgary (CA)
- Corresponding author
- Laupland, Kevin B.
- Venue
- Journal of Antimicrobial Chemotherapy
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-06-18
- Volume
- 60
- Issue
- 3
- Pages
- 613-618
- ISSN
- 0305-7453 (ISSN-L)
- 1460-2091
- OpenAlex
- W2137351193
- Semantic Scholar
- 80b38a8f43278681a310601609c65ad32cfe938e
- Cited by
- 229
- References
- 32
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 2 · 2023: 1 · 2022: 7 · 2021: 5 · 2020: 6 · 2019: 9 · 2018: 4 · 2017: 14 · 2016: 15 · 2015: 10 · 2014: 17 · 2013: 20 · 2012: 17
- FWCI
- 13.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Antimicrobial Chemotherapy (publishedVersion)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
- Keywords
- invasive candidiasis, empirical antifungal therapy, treatment adequacy, mortality, Candida albicans, Candida glabrata, fungemia, cerebrospinal fluid culture, guideline adherence
- MeSH terms
- Adult, Aged, Aged, 80 and over, Alberta, Analysis of Variance, Antifungal Agents, Calibration, Candida, Candidiasis, Female, Humans, Male, Microbial Sensitivity Tests, Middle Aged, Terminology as Topic, Risk Factors, Cohort Studies, Logistic Models, Odds Ratio, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.